Goodwin > London, England > Firm Profile
Goodwin Offices
100 CHEAPSIDE
LONDON
EC2V 6DY
England
- Go to...
- Rankings
- Firm Profile
- Main Contacts
- Lawyer Profiles
Goodwin > The Legal 500 Rankings
Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m) Tier 1
Drawing on its firmwide expertise in tech and healthcare, Goodwin‘s sizeable team handles a healthy volume of sponsor-side buyout work targeting the sectors, including a number of cross-border acquisitions and investment deals for both PE firms and their portfolio companies. Practice head Richard Lever maintains a wide-ranging transactional practice, most recently advising on acquisitions in the real estate and education sectors. James Grimwood handles a range of tech and growth-oriented deals, while Carl Bradshaw‘s recent workload includes consumer goods and financial services mandates. Other key figures include London office co-chair Gemma Roberts, noted for her experience in carve-outs and growth equity investments, and Michael Miranda, recommended for his focus on transatlantic tech deals.Practice head(s):
Richard Lever
Other key lawyers:
Key clients
Accel-KKR
Bregal Milestone & Bregal Sagemount
G Square Private Equity
IK Investment Partners
Lloyds Development Capital
Mayfair Equity Partners
Queens Park Equity
Summit Partners
TA Associates
TowerBrook Capital Partners
Work highlights
- Advised Mayfair Equity Partners on its investment in LoopMe and on its sale of Talon Outdoor to Equistone.
- Advised AKKR on its buyout of PayProp.
- Advised IK Partners on its acquisition of International Correspondence Schools.
Corporate and commercial > Venture capital Tier 1
Although it remains a relatively new practice in the market, in a short space of time, under the assured guidance of David Mardle, Goodwin has firmly established itself as one of the leaders in the space, with a level of expertise in the tech and life sciences sectors that is a match for its more established US counterpart. Key to this rapid success story has been the firm’s hiring policy, which has cherry-picked some of the leading practitioners in the market at rival firms, as well as its holistic approach (drawing upon IP, employment and tax advice) which ensures that innovators and investors receive a joined-up service throughout the investment life cycle. Ali Ramadan has ‘exceptional start-up and biotech knowledge’, and has been integral to the firm’s success, providing ‘technically excellent advice’ to investees and investors throughout the funding cycle, including as it relates to work at the intersection of property and technology. With a core focus on impact investing, including on healthtech deals, Sophie McGrath continues to impress, as does Cambridge-based Elizabeth Rhodes and Andrew Davis, who has ‘immense gravitas for a young partner’. The investment the firm continues to make in the area is also highlighted by a number of recent internal partner promotions, including Cambridge-based practitioner Adam Thatcher, whose versatile practice includes work for investors and investees in the fintech, life sciences, healthcare and technology sectors, and Kenny Walker-Durrant, who has ‘incredible technical skills on the tech and life sciences sectors’.Practice head(s):
David Mardle
Other key lawyers:
Sophie McGrath; Ali Ramadan; Andrew Davis; Elizabeth Rhodes; Adam Thatcher; Kenny Walker-Durrant; Richard Bloomfield; Ella Donegan; Charles Baker
Testimonials
‘Diverse expertise and capabilities throughout the firm means they can support early-stage companies across any legal matters.’
‘Solid team with a lot of experience. Flexible with fees. Very commercial advice. Know the market well.’
‘Ali Ramadan – calm in negotiations, very knowledge in the VC space and technically excellent.’
‘Ali Ramadan is exceptionally thorough in negotiations with investors, resulting in speedy and very positive results. He is also excellent at communicating complex issues to clients.’
‘Ali Ramadan has exceptional start-up and biotech knowledge.’
‘Andrew Davis has immense gravitas for a young partner.’
‘Kenny Walker-Durrant has great market knowledge, fast and pragmatic advice and turnaround on documents.’
‘Kenny Walker-Durrant – real talent with incredible technical skills on the tech and life sciences sectors.’
Key clients
Probe Test Solutions Limited
Refeyn Limited
Cleo AI Ltd
Ten Eleven Ventures
Gilde Healthcare Partners
Kaiser Permanente Ventures
Morningside Ventures
Vivo Capital LLC
Kinnevik Capital Limited
Hoxton Farms Ltd
Omnipresent Group Limited
MiroBio Ltd
Oxford Science Enterprises PLC
Syncona Portfolio Limited
Lakestar III LP
SV Health
Jeito
Samsara BioCapital
Cherry Ventures Fund IV GmbH & Co
Octopus Ventures
Material Impact
Dr. Martens
Work highlights
- Advised Kinnevik Capital Limited on its lead investment into Mews Systems as part of an $185m Series C round.
- Advised Oxford Science Enterprises PLC and Syncona Portfolio Limited on their investments into OMass Therapeutics Limited as part of OMass’s $100m Series B funding round alongside new investors GV, Northpond and Sanofi.
- Advised Omnipresent on its $120m Series B funding round.
Investment fund formation and management > Real estate funds Tier 1
The real estate investment funds team at Goodwin is well placed to handle cross-border funds matters by virtue of its global network, which fields dedicated practitioners across Europe, including in the key jurisdictions of London, Paris, Luxembourg and Frankfurt. The group is led by Samantha Lake Coghlan and Justin Cornelius, with Coghlan advising fund managers and investors on the structuring, establishment, operation and restructuring of funds, and Cornelius being a name for unlisted closed- and open-ended real estate funds, joint ventures and M&A. David Evans acts for investment banks, family offices, hedge funds and private equity managers on UK and pan-European funds. Other key practitioners include Bhargavi Mudakavi, who was promoted to partner in October 2022, and Niall Dickson. The group was recently bolstered by the arrival of Eric Lim, Jacqueline Eaves and Andrew Henderson, who joined from Baker McKenzie, Kirkland & Ellis International LLP, and Macfarlanes LLP respectively.Practice head(s):
Samantha Lake Coghlan; Justin Cornelius
Other key lawyers:
David Evans; Adnan Bhaiji; Bhargavi Mudakavi; Eric Lim; Jacqueline Eaves; Andrew Henderson; Niall Dickson
Testimonials
‘Goodwin have a good reach across the RE funds sector and so understand the market and its evolution.’
‘Justin Cornelius is a long term stand out advisor for us. His knowledge of the market and of our firm’s capabilities and the ability to communicate to all the team regardless of topic is impressive.’
Key clients
NREP
Patron
Frogmore
Kennedy Wilson
Slate Asset Management
Cabot Properties
Ares Management
BentallGreenOak
Nuveen
Clearbell
Work highlights
- Advised leading pan-Nordic real estate investment manager, NREP on the establishment and fundraising of their open-ended core/core-plus real estate fund, Income+.
- Advising Kennedy Wilson on the formation of its second programmatic joint venture to acquire and manage urban logistics properties in the UK, Ireland and Spain, targeting a total portfolio of $1.5bn.
- Advised on the establishment and fundraising of Clearbell Capital Partners IV LP, the fourth in the series of value-add and opportunistic funds targeting investments in the UK.
Corporate and commercial > Corporate and commercial: Cambridge Tier 1
Goodwin's Cambridge office is a key hub for the firm-wide technology and life sciences practice, which has a prominent global profile. The firm advises private and public companies, venture capital funds and investment firms on early-stage financings, capital market transactions, M&A deals, strategic collaborations and licensing matters in this context. David Mardle, Malcolm Bates and Tim Worden are the lead partners. Adam Thatcher who was promoted to partner in October 2022 and Elizabeth Rhodes play key roles in tech in VC and M&A transaction work, namely. The team is noted as being ‘smart and responsive, with good depth of skill and experience in complex transactions'.Practice head(s):
Malcolm Bates; David Mardle; Tim Worden
Other key lawyers:
Adam Thatcher; Elizabeth Rhodes; Roshni Thakkar
Testimonials
‘Knowledgeable on venture capital, extremely responsive, good risk mitigations.’
‘We have a genuine relationship with the team who always seek to understand circumstances and context.’
‘Smart and responsive, with good depth of skill and experience in complex transactions.’
‘A trusted advisor with breadth of experience, responsiveness and availability.’
‘Extensive experience of commercial transactions; a highly pragmatic approach, efficient and expeditious in providing advice. Excellent value for money.’
‘Elizabeth Rhodes is extremely commercial and effective, and has a very talented group of associates including Roshni Thakkar, who deserves particular mention. The team is highly commercial with a focus on getting a deal done. They have proven excellent at learning how we as a client like to work with external advisers, and what our limits are, and now implement this consistently.’
‘We trust the Cambridge team’s judgement and have confidence in them striking the right balance between attention-to-detail and not overworking a matter. The team is well run, consistent in their approach, transitions are smooth and all are a pleasure to work with.’
‘Elizabeth Rhodes is highly commercial, a clear and efficient communicator, and resilient in negotiations. She learns her clients, their preferences and limits, and ensures that she and her team take as much as they can upon themselves. Roshni Thakkar is excellent – technically completely sound, has a strong commercial outlook, with excellent communication and project management skills.’
Key clients
Okra.ai
Refeyn Limited
Oxford Science Enterprises PLC
Syncona Portfolio Limited
Engitix Limited
SynAffix B.V.
Stalicla SA
Probe Test Solutions Limited
Ten Eleven Ventures
MiroBio Ltd
Flusso
Cleo
SV Health Investors
Jeito
Samsara BioCapital
Biocon Biologics Ltd
YASA
Moderna
Tay Therapeutics
Work highlights
- Advised OKRA.ai on their acquisition by Envision Pharma Group (Envision)
- Advised Refeyn on its oversubscribed Series B financing. The round was led by Northpond Ventures, a scientific, medical, and technology-driven venture firm and supported by existing investors, including Oxford Science Enterprises, Foresight Group, Oxford University and Horizons Ventures.
- Advised Oxford Science Enterprises PLC and Syncona Portfolio Limited on their investments into OMass Therapeutics Limited as part of OMass’s $100m Series B funding round alongside new investors GV, Northpond and Sanofi.
TMT (technology, media and telecoms) > Biotechnology Tier 1
At Goodwin in Cambridge, ‘the team provides timely, pragmatic and and commercial advice‘ and clients note that the lawyers are ‘accessible, responsive and keen to understand our aims‘. David Mardle has broad expertise in life sciences, technology, M&A, and finance matters; commercial IP specialist Malcolm Bates, who has ‘broad and long experience' in R&D projects and collaboration agreements; and licensing and contracts expert Tim Worden are key to the practice. Worden acted as part of a multinational team to advise Biocon Biologics on its multibillion-dollar acquisition of the global biosimilars business of its partner Viatris Inc. Up-and-coming partner Elizabeth Rhodes handles corporate and venture capital matters for technology and life sciences companies.Practice head(s):
Malcolm Bates; David Mardle; Tim Worden
Other key lawyers:
Testimonials
‘The team provides timely, pragmatic and and commercial advice on our licensing activities which we find very valuable. They are accessible, responsive and keen to understand our aims during transactions and regularly help us navigate complex scenarios given their knowledge and expertise in the market.’
‘Tim Worden provides us with expert coverage as our key contact as well as high quality, deal-specific advice on our licensing activities. He has pulled in trans-Atlantic resources on deals when we have needed it seamlessly and delivers a really high-quality service.’
‘We work especially with Malcolm Bates. Malcolm’s broad and long experience makes interactions and processes run smoothly and efficiently.’
Key clients
Biocon Biologics
Syndesi Therapeutics
Okrai.ai
Refeyn Limited
Oxford Science Enterprises PLC
Engitix Therapeutics
Synaffix BV
Stalicla SA
Ten Eleven Ventures III, LP
MiroBio Ltd
SV Health Investors
CMR Surgical
Ochre Bio, Inc
Gadeta
Work highlights
- Advised Biocon Biologics Ltd on its multi-billion-dollar acquisition of the global biosimilars business of its partner Viatris Inc.
- Advised Synaffix B.V on three license agreements: with Genmab A/S; with Amgen Inc; with Hummingbird Bioscience.
- Advised Stalicla SA on an in-licensing agreement with Novartis.
TMT (technology, media and telecoms) > Intellectual property Tier 1
The Cambridge based team at Goodwin specialises in assisting clients with IPOs, financings, and patent strategies. The team recently assisted Engitix Therapeutics on a licence and collaboration agreement with Takeda Pharmaceuticals USA, Inc. Practice co-head Malcolm Bates specialises in the commercialisation of intellectual property rights, and co-head Tim Worden regularly advises life sciences companies on licensing and partnering deals, R&D and clinical trials agreements, and a broad spectrum of regulatory matters. Counsel Talitha Shkopiak focuses on commercial agreements, and associate Georgia Powell whose work encompasses early stage contractual disputes, are also pivotal to the practice.Practice head(s):
Malcolm Bates; Tim Worden
Other key lawyers:
Key clients
Engitix Limited
SynAffix B.V.
Stalicla SA
CMR Surgical
Gadeta
Pheon Therapeutics
MiNA Therapeutics
Avacta
SpyBiotech
Tenpoint Therapeutics
Work highlights
- Advised Synaffix B.V. on a license agreement with Amgen Inc.
- Advised Engitix Limited on entering into an expanded licence and collaboration agreement with Takeda Pharmaceuticals.
- Advised Stalicla SA on its exclusive in-licensing agreement with Novartis.
Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m Tier 2
Goodwin is a strong choice for clients across the real estate, technology and life sciences arenas, who seek out the ‘outstanding’ team of M&A lawyers for its ‘deep sector knowledge’ and ‘global experience.’ The team frequently acts for clients on the buy and sell side in a full spectrum of transactions including divestitures, mergers and acquisitions, spinoffs, joint ventures and stock deals. The group of lawyers heading up the practice include: Graham Defries, who also co-chairs the firm’s UK life sciences team; the ‘extremely competent’ David Mardle, who offers significant experience in M&A and capital markets in relation to technology, life sciences and emerging companies; James Spence, who is a specialist in domestic and cross-border real estate M&A and investment transactions; and the ‘remarkable’ Andrew Davis, who attracts praise from large corporates and venture capital investors in the life sciences, technology and media sectors. Other key figures include Ali Ramadan, Adam Thatcher, Raymond Fang and Kenny Walker-Durrant. Venture capital, M&A and private equity practitioner, Richard Bloomfield, is also recommended.Practice head(s):
Graham Defries; David Mardle; James Spence; Andrew Davis
Other key lawyers:
Testimonials
‘Highest caliber people with a very sophisticated approach to transactions.’
‘Graham Defries is simply the best. He is sharp, reads the room well, hugely experienced and advises clients on all aspects of the transaction.’
‘Having worked with Goodwin for a number of years they demonstrated a strong understanding of our business combined with a depth of M&A experience.’
‘Adam Thatcher is a very strong technical lawyer and understanding, giving confidence in terms of process and execution. Richard Bloomfield also has a good technical understanding and good project management abilities to ensure delivery of collateral to schedule.’
‘Goodwin have an outstanding M&A team with global experience and reach. They are particularly strong on UK-US transactions. They are fast, efficient and available whenever needed and they find solutions to even the most intractable-seeming problems. They are superb.’
‘Andrew Davis is just remarkable. He has a huge amount of expertise and is a joy to work with. In any transaction 101 different issues are going to emerge and he just steers you through them all with confidence, charm and humour.’
‘The team led by David Mardle is extremely competent and made the entire process much easier for us. David Mardle had been highly recommended by our M&A advisory team. We found the legal advice on aspects of long-standing contracts to be of high quality. It was reassuring to have the assistance of a great legal team behind us during the transaction, covering all aspects fast and diligently. We felt that with David Mardle, Adam Thatcher and their team, we were very well looked after. We would have no hesitation in recommending their services or indeed, using them again.’
‘Deep sector knowledge and a large, experienced team that know the market and market norms.’
Key clients
Biocon Biologics Ltd
Ducentis BioTherapeutics Ltd
DJS Antibodies Ltd
MiroBio Ltd
ReViral Limited
Play Ventures Pte Limited
Backed 2 GP Limited
Codeplay Software Limited
Symphonic Solutions Limited
Profile FSH Limited
FARO Technologies, Inc
Knowledgemotion Limited
Future Health Works Ltd
Frogmore
Kennedy Wilson
Citymapper
OKRA.ai
Mayfair Equity Partners
HUMA Therapeutics
Work highlights
- Advised Biocon Biologics Ltd. on its US$3.335 billion acquisition of the global biosimilars business of its partner Viatris Inc.
- Advised Citymapper Ltd on the sale of its entire issued share capital to Via Transportation, Inc.
- Advised global real estate investment manager Kennedy Wilson on the acquisition of a portfolio of logistics assets located in the United Kingdom from Leftfield Advisors for a purchase price of c.£228 million.
Investment fund formation and management > Private funds Tier 2
Goodwin regularly handles large scale fund structuring, raising and closing matters across a range of funds, including private equity, venture capital, real estate, infrastructure and debt. The practice is led by Michael Halford, who specialises in advising managers and investors on private equity and investment fund structuring. Also key are infrastructure private equity expert Ed Hall, private debt and infrastructure and energy funds specialist Shawn D’Aguiar and the fund regulation and management focused Ajay Pathak. Ravi Chopra is a key name of note within the team, and Benjamin Yeoh was promoted to partner in October 2022.Practice head(s):
Michael Halford
Other key lawyers:
Ed Hall; Ravi Chopra; Ajay Pathak; Shawn D’Aguiar; Benjamin Yeoh; Patrick Deasey
Testimonials
‘Deep Experience and knowledge of the market across the globe.’
Key clients
Abingworth
Antin Infrastructure
Bregal Investments
Endless
Glennmont Partners
Intermediate Capital Group (ICG)
Investcorp
LGT
Macquarie
Patron Capital
Work highlights
- Advised ICG on the structuring and fundraising of its eighth European Corporate fund.
- Advising Ambienta on the formation and fundraising of Ambienta Fund IV.
- Advised Longship on the fundraising and closing of Longship Fund III LP, a NOK 2.1 billion (c. €200 m) private equity fund focused on the Norwegian lower mid-market.
Industry focus > Hospitality and leisure Tier 3
Co-operating closely with the practice in the United States, the team at Goodwin assists clients from both the brand and operator, and debt and equity investor sides, with hotel, resort and branded residential matters. The team has a broad offering covering assistance with transactions such as acquisitions, dispositions, and financings, and also handles associated dispute resolution, tax, employment and regulatory matters. Acting for a range of stakeholders in this space and heading up the team is 'top-notch' Matthew Pohlman. Martin Smith is another key lawyer, who advises investor clients on acquisition, disposal, and management and branding of hotel and leisure assets.Practice head(s):
Matthew Pohlman
Other key lawyers:
Testimonials
‘An exceptional firm with a high-quality partner heading up the hospitality practice.’
‘Matthew Pohlman is an exceptional lawyer, excellent communicator, excellent negotiator. He is a top-notch human being. He is enjoyable to work with, extremely responsive and available, with a fast turnaround time on complex issues. I cannot say enough good things about him.’
‘The team is very responsive and dedicated. The work is distributed among lawyers based on relevant expertise and it seems there is good integration among them.’
‘I worked mainly with Matthew Pohlman and I found him very effective in negotiation. He has a very deep knowledge of the market and the client so he is capable of providing efficient support to the specific matter.’
‘Goodwin has a partner in London who may be the best in the UK/EU market (Matthew Pohlman). If and when he needs to, Matthew can draw from a very savvy coterie of hotel and resort lawyers in the United States. The luxury hotel industry in particular has become global, and Matthew is one of the stars.’
‘Matthew Pohlman has years of hotel and resort industry experience, particularly in the luxury sector, not common in UK and EU-based law firms. Because of this very successful focus, he stands out as an international industry star, and is very well recognised for his talent, as well as his experience. He is my number one choice if I need to make a referral to UK-based talent in the luxury hotel field.’
‘Doing work on both sides of the owner-operator continuum gives Goodwin a wide view of the issues and approaches.’
‘Matthew Pohlman is a standout lawyer, incredibly hard working and responsive to client needs.’
Key clients
Four Seasons Hotels and Resorts
Caesars Entertainment Corporation
Oaktree Capital Management
RoundShield Partners LLP
Angelo, Gordon & Co
Crossroads Real Estate
Firmdale Hotels
Cairn Hotel Group
Masterworks Development Corporation (a/k/a Club Quarters)
Away Resorts
Leeu Collection
Avington Financial
Hyatt Hotels
Work highlights
- Advised Frogmore’s fourth value add fund, Frogmore Real Estate Partners IV, on the acquisition of the corporate structure owning the Hilton London Olympia from HPL Olympia, a subsidiary of Singapore-listed Hotel Properties, as well as the related formation of a joint venture platform with hotel and serviced apartment investor C1 Capital Partners.
Industry focus > Life sciences and healthcare Tier 3
Praised for its ‘constructive and problem-solving‘ approach to issues, the team at Goodwin advises a diverse client roster, which notably includes DJS Antibodie, Novo Holdings and Ducentis BioTherapeutics. Practice co-head David Mardle primarily assists emerging companies with M&A, and co-head Graham Defries advises a number of investors, and biotech and pharmaceutical companies on venture capital exits and investments, in addition to licensing transactions. Co-head Malcolm Bates has broad knowledge surrounding collaborations, outsourcings, and R&D project transactions. Morag Peberdy acts for corporates, having a great deal of expertise in the IP aspects of IPOs and venture capital investments, in addition to IP pipeline arrangements. Kenny Walker-Durrant was promoted to partner in October 2022, and focuses on advising emerging growth companies on corporate matters.Practice head(s):
David Mardle; Graham Defries; Malcolm Bates
Other key lawyers:
Andrew Harrow; Tim Worden; Morag Peberdy; Kenny Walker-Durrant
Testimonials
‘Broad range of skills and areas they can help with.’
‘Approachable and client-friendly, partners stay involved.’
‘Constructive and problem-solving approach.’
Key clients
Refeyn Limited
MiroBio Ltd
Morgan Stanley & Co., Inc
William Blair
Oxford Science Enterprises PLC
Syncona Portfolio Limited
DJS Antibodies Limited
Ducentis BioTherapeutics Ltd
ReViral Limited
Biocon Biologics Ltd
Syndesi Therapeutics
Vivo Capital LLC
Boehringer Ingelheim Venture Fund GmbH
Novo Holdings A/S
Evotec SE
Engitix Limited
SynAffix B.V.
Stalicla SA
Grey Wolf Therapeutics Limited
Work highlights
- Advised Morgan Stanley and William Blair, which acted as joint bookrunners for Silence Therapeutics plc’s underwritten ADS offering for gross proceeds of approximately $56.5m.
- Advised Syndesi Therapeutics and its shareholders in relation to the sale of Syndesi’s entire issued share capital to AbbVie.
- Advised Biocon Biologics Ltd on the completed acquisition of substantially all of the global biosimilars business of Viatris Inc. for a total purchase price of $3.3bn.
Real estate > Commercial property: investment Tier 3
Often working in conjunction with the practice’s finance, funds, regulatory and tax teams, Goodwin is well-placed to advise clients throughout the full lifecycle of an investment transaction. Praised for his ‘exceptional knowledge’, practice co-leader Martin Smith acts on asset and corporate SPV mandate, while team co-head James Spence is a key contact for a plethora of stakeholders, and David Evans is noted for his expertise in fund restructuring. Simon Woodcock, who advises on real estate M&A, as well as asset management agreements, is another key contact in the group.Practice head(s):
James Spence; Martin Smith
Other key lawyers:
David Evans; Simon Woodcock; Eric Lim; Justin Cornelius; Adnan Bhaiji
Testimonials
‘Martin Smith is a long-standing and trusted contact. He has exceptional knowledge and is highly diligent.’
‘A strong multi-disciplinary team who can provide a full-service offering.’
‘Eric Lim is an outstanding lawyer who makes his clients feel like he is only working for them. Eric gives balanced, considered advice and thinks about the situation from a variety of angles.’
Key clients
Kadans Science Partner
Partners Group
Frogmore
Fidera Vecta
The Townsend Group
BentallGreenOak
Kennedy Wilson
Crossroads Real Estate
Tokoro Capital
Medical Properties Trust
Work highlights
- Advised Kadans Science Partner on the acquisition of a long leasehold interest at Canary Wharf’s North Quay as well as a development platform with Canary Wharf Group to build a sustainable lab enabled building.
- Advised Frogmore Real Estate Partners IV, L.P., on the acquisition of the corporate structure owning the Hilton London Olympia from HPL Olympia Pte Ltd.
- Advised global real estate investment manager Kennedy Wilson on the acquisition of a portfolio of logistics assets from Leftfield Advisors.
Corporate and commercial > Corporate tax Tier 4
Goodwin‘s rapidly growing team is noted for its strength in the tax elements of M&A transactions, and fund structuring. Team lead Laura Charkin specialises in funds taxation, and is a leading name in matters related to REITs. David Irvine, who has expertise in structuring and restructuring transactions, and Dulcie Daly, whose focus is private equity, joined the team from Kirkland & Ellis International LLP in 2021. Katie Leah‘s practice includes real estate and private equity transactions, while Charlotte Haywood handles the structuring of European based private funds.Practice head(s):
Laura Charkin
Other key lawyers:
David Irvine; Dulcie Daly; Katie Leah; Charlotte Haywood; Matthew Birchall
Testimonials
‘Smart, responsive and pragmatic approach to resolving transactional tax issues.’
‘Dulcie Daly comes across very well, both in writing and in conference – she is sharp and to the point, and focuses on getting the parties to the destination, rather than trying to prolong the debate over who is ‘most right on tax’.’
‘The team at Goodwin are very professional and always very responsive. They have worked in the PE industry for many years and are very capable at converting commercially agreed points into legal documents.’
‘Impressive size, calibre and experience of tax team. Goodwin’s investment in the UK market is noticeable in comparison to their peers.’
‘I have worked with Laura Charkin and Charlotte Haywood for a number of years. They are always proactive and practical and balance often technical questions and issues with a commercial and pragmatic approach.’
Key clients
Macquarie
Bregal Investments
Ambienta
TA Associates
Glennmont Partners
AKKR
Sky
Mayfair Equity Partners
LGT Capital Partners
TowerBrook Capital Partners
Work highlights
- Advised Intermediate Capital Group on the fundraising of its eighth European Corporate fund. The Fund held a final close with a total fund size of €8.1 billion.
- Advised Kadans Science Partner on the acquisition of a long leasehold interest at Canary Wharf’s North Quay, alongside the establishment of a development platform in joint venture with Canary Wharf Group.
- Advised TowerBrook on its acquisition of Premium Credit Limited from Cinven.
Corporate and commercial > Private equity: transactions – high-value deals (£250m+) Tier 4
The team at Goodwin in London acts for a range of clients – both sponsor and management-side – on a steady flow of high-value transactions, particularly in the healthcare, life sciences, tech, and infrastructure sectors. Practice head Richard Lever – experienced in both domestic and multijurisdictional matters – in an active adviser whose recent highlights include a number of portfolio company deals. Carl Bradshaw regularly handles all manner of deals across European markets, while London office co-chair Gemma Roberts is particularly noted for her experience in cross-border carve-outs. Christian Iwasko and James Grimwood are also recommended for their broad transactional acumen.Practice head(s):
Richard Lever
Other key lawyers:
Carl Bradshaw; Gemma Roberts; Christian Iwasko; James Grimwood; Michelle Tong
Key clients
Accel-KKR
Bregal Milestone & Bregal Sagemount
G Square Private Equity
IK Investment Partners
Lloyds Development Capital
Mayfair Equity Partners
Queens Park Equity
Summit Partners
TA Associates
TowerBrook Capital Partners
Work highlights
- Advised CSafe, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, on the completion of its acquisition of Softbox.
- Advised TA Associates (together with its affiliated investment funds, “TA”) on a minority investment in Apex Group Ltd.
- Advised TowerBrook on its acquisition of Premium Credit Limited from Cinven.
Real estate > Property finance Tier 4
Paul Lyons leads Goodwin‘s real estate practice, and is known for his significant experience in advising both borrowers and lenders on leveraged finance, debt finance and debt originations. Fellow senior partner Richard Semple remains active in domestic and pan-European acquisitions of portfolios of loans. Counsel Toby Young represents sponsors on borrower mandates and as lender counsel for the deployment of real estate focussed debt funds.Practice head(s):
Paul Lyons
Other key lawyers:
Key clients
BentallGreenOak
Meadow Partners
Ares Funds
London Square Developments
Partners Group
Work highlights
- Advised BentallGreenOak on three logistics portfolio development financings amounting to £400 million in aggregate.
- Advised London Square Developments Limited on the Nine Elms Development financing.
- Advised Meadow Partners, as mezzanine lenders, on four development financings.
Finance > Acquisition finance Tier 5
Focusing on acquisitions in firmwide core industry sectors, including tech, life sciences and property, Goodwin continues to actively advise on behalf of a growing roster of private equity funds, which are appreciative of the firm's expertise advising on debt financing techniques throughout the capital structure. Simon Fulbrook and Hugh O’Sullivan co-head the team.Practice head(s):
Simon Fulbrook; Hugh O’Sullivan
Other key lawyers:
Richard Hughes; Thomas Plowman
Testimonials
‘Goodwin has worked with us accessing large direct deals and small mid-market deals. The same team there can lead appropriate documentation for both – this is unique’
‘Stand-out knowledge from Hugh O’Sullivan from legal issues on large to small-market terms. He also understands the inner workings of banks which helps management as much as it helps our firm.’
Key clients
ECI Partners
TowerBrook Capital Partners
LDC
Mayfair Equity Partners
Partners Group
Queens Park Equity
TA Associates
Bregal Milestone
Tiancheng International Investment
Wavecrest Partners
G Square Private Equity
H.I.G. Capital
Inflexion
Accel-KKR
Thoma Bravo
Work highlights
- Advised TowerBrook Capital Partners on the financing to facilitate its acquisition of leading provider of premium finance for commercial and retail insurance products Premium Credit Limited from Cinven.
- Advised Biocon Biologics Ltd. (India’s largest biotech company) on the financing to facilitate its $3.33bn acquisition of the global biosimilars business of its partner Viatris Inc.
- Advised Accel-KKR on the debt financing for its acquisition of the PayProp group and the co-investment in the PayProp group by a consortium of its existing shareholders.
Finance > Corporate restructuring & insolvency Tier 5
The ‘innovative and ambitious’ team at Goodwin continues to gain market traction among funds and IPs, in particular, which are appreciative of the team’s versatility across restructuring and formal insolvency work, as well as its ability to draw from other core firmwide sector strengths, including tech and life sciences. Simon Thomas is ‘very innovative’ and has been key to the firm’s success since establishing a UK offering in 2019, not only due to his transactional and technical expertise but also his ability to leverage the firm’s US credentials to good effect on cross-border mandates. The principal author of the market leading textbook on UK restructuring tools, Geoff O’Dea‘s ‘depth of knowledge in UK restructuring techniques is unsurpassed’, and he complements his co-head Thomas’ more cross-border focused offering. Counsel Tony Horspool is also a ‘highly experienced and very capable’ member of the team by dint of his work for private equity firms on special situations and restructurings.Practice head(s):
Simon Thomas; Geoff O’Dea
Other key lawyers:
Oonagh Steel; Emily Lockhart; Tony Horspool; Thomas Plowman
Testimonials
‘It is a very focused and knowledgeable team that seems to understand not only the commercial and legal implications of restructuring but also the personal ones.’
‘A strong, well connected team that is innovative and ambitious.’
‘Simon Thomas – innovative and works collaboratively to progress matters across multiple sectors.’
‘Geoff O’Dea is a heavyweight presence in the market. His depth of knowledge in UK restructuring techniques is unsurpassed.’
‘Tony Horspool is a highly experienced and very capable lawyer.’
‘Oonagh Steel is technically very strong and has great case management skills.’
Key clients
Permira Credit Limited
Teneo
Flexenable Limited
Galaed / Aurora Lighting
T0day Group
Kroll Advisory
Interpath Advisory
EY
Madison Pacific
Alvarez & Marsal
FRP
Stellex Capital
Kroll Trustee Services
PwC
TowerBrook Capital Management / The Learning Network
Evolito
Sixth Street
Work highlights
- Advised Madison Pacific Trust on several phases of the Noble Group restructuring with a combined aggregate value of $2.35bn.
- Advised Galaed as the acquirer of the global trade Aurora Lighting business from Alvarez & Marsal (administrators).
- Acted for TowerBrook Capital Management and its portfolio company TLN in connection with TLN’s ongoing restructuring.
Risk advisory > Data protection, privacy and cybersecurity Tier 5
Jointly led by Lore Leitner and Gretchen Scott, the data, privacy, and cybersecurity practice at Goodwin has a full-service offering with particular strength advising clients in the emerging tech, software, and healthcare and life sciences sectors. The team also includes ‘highly knowledgeable’ counsel Curtis McCluskey and senior associate Josephine Jay, recommended for her data compliance and GDPR expertise.Practice head(s):
Lore Leitner; Gretchen Scott
Other key lawyers:
Curtis McCluskey; Josephine Jay; Annabel Loose
Testimonials
‘The Goodwin privacy team is knowledgeable, pragmatic, responsive, and really personable and helpful. I have built a great relationship with them and enjoy our interactions and knowledge-sharing.’
‘I have forged great relationships with Gretchen Scott and Curtis McCluskey. As well as respecting and valuing their professional opinions and knowledge, I also really enjoy their company when we have an opportunity to connect socially at events.’
‘Gretchen Scott has a helicopter view of the GDPR and legislation around different countries, a great understanding of the situation and the business needs, and clear judgement. Curtis McCluskey is very knowledgeable, has a helicopter view of the GDPR and legislation around different countries, quick responses and writing of legal documents, always up to the point with a great understanding of the situation.
‘Josephine Jay has great knowledge of GDPR, quick responses and writing of legal documents, always up to the point with a great understanding of the situation, strong on defending the legal choices in writing and in talking.’
‘The Goodwin data protection team demonstrates an exceptional depth of knowledge and a remarkable ability to bridge the gap between the legal framework and practical implementation. Their expertise and insights enable them to provide legal opinions that are not only accurate and reliable but also aligned with the practical needs and goals of their clients. The team consistently goes above and beyond, going the extra mile to ensure the best possible service.’
‘Lore Leitner consistently showcases a deep understanding of data protection compliance and industry expertise. She is skilled at providing well-rounded advice that balances legal compliance with commercial objectives. Annabel Loose provides sound and actionable legal advice and exhibits exceptional responsiveness. Working with them has been a pleasure.’
‘The team are incredibly commercial in their approach and take the time to think about how advice is presented, and the format which would be more accessible and digestible for a busy in-house lawyer. The people are fantastic and a pleasure to work with.’
‘Lore Leitner is a superstar and so knowledgeable. She doesn’t waste your time either. I appreciate her no nonsense, commercial approach to data protection and would always recommend her.’
Key clients
Luka, Inc. (dba Replika)
Chaos Software EOOD; Chaos Group
Wayfair
Semrush, Inc
Transmit Security
CMR Surgical Limited
Medidata Solutions, Inc.
HungryPanda Limited
AM Pharma B.V.
Apart Of Me
HubSpot, Inc.
Thomson Reuters Corporation
HIBio, Inc
Citymapper
ZYNC, Inc
Audio Analytic Limited
Meta Platforms, Inc.
SilkRoad Technology, Inc.
Work highlights
- Assisted Luka, Inc. (dba Replika) in addressing the concerns raised by the Italian Data Protection Authority (“Garante”) and in implementing the necessary changes to comply with the order.
- Advised Wayfair’s on centralising its approach to privacy, and strategically positioning itself to ensure compliance supports its business objectives around data and advertising its products.
- Advised Transmit Security on building and developing its GDPR compliance (including advising on its data protection classification – either a processor or controller in relation to each aspect of its products) following its expansion into the EU and UK markets.
TMT (technology, media and telecoms) > Fintech Tier 5
Goodwin‘s fintech offering draws on wider expertise in venture capital, financial services regulation and tax matters. The team also has a key strategic focus on supporting entrepreneurs and early-stage fintech companies. The practice is jointly run by three partners; Andrew Davis, who specialises in corporate transactions; Andrew Henderson, an authority on financial services regulation who joined from Macfarlanes LLP in June 2022; and Ali Ramadan, a key contact for venture capital and private equity transactions. Glynn Barwick‘s regulatory expertise extends to EU and UK competition and merger control issues. Emerging growth companies frequently turn to Adam Thatcher for corporate advice, while James Taylor leverages his expertise in intellectual property matters to assist clients in the fintech space. Arvin Abraham, a former bank COO and an expert in fintech investments, joined from McDermott Will & Emery UK LLP in July 2023.Practice head(s):
Andrew Davis; Andrew Henderson; Ali Ramadan
Other key lawyers:
Glynn Barwick; David Mardle; Adam Thatcher; James Taylor
Testimonials
‘Very professional team, knowledgeable of the relevant legal and regulatory matters. Very good attitude towards client work and pragmatic views towards finding solutions.’
‘Andrew Henderson is an experienced professional. Has a very hands-on approach on client matters and is readily available.’
Key clients
FNZ
Koos
Fidelity International Strategic Ventures
Galaxy Digital
Cleo AI
Vivid Money
Lightspeed Venture Partners
Octopus Ventures
Work highlights
- Assisted in FNZ’s approx. €12 million purchase of the issued share capital of B2B fund platform, ifsam – International Fund Services & Asset Management S.A.
- Advising Koos on regulatory aspects of their token platform.
- Fidelity International Strategic Ventures £20 million investment into Moneybox as the lead investor in a £35 million ($45,791,900) Series D funding round.
Dispute resolution > Commercial litigation: premium Tier 6
Goodwin has a ‘dynamic and growing litigation team‘ with vast expertise across the private equity, funds, venture capital, and financial service industries. The practice was launched in April 2020 with the arrival of ‘first class litigator‘ Oliver Glynn-Jones from Bryan Cave Leighton Paisner, who works across corporate and financial litigation. The bench strength of the team continues to expand, with the firm adding Sarah McAtominey from Bryan Cave Leighton Paisner in early 2023.Practice head(s):
Oliver Glynn-Jones
Other key lawyers:
Sarah McAtominey; Grace Boos
Testimonials
‘A dynamic and growing litigation team, ably led by the excellent Oliver Glynn Jones.’
‘Oliver Glynn Jones is a first class litigator, combining excellent judgement with an easy manner. He’s totally committed to his clients and always focused on achieving the optimum outcome in any dispute.’
‘I have been impressed by the collaborative work. It’s clear partners listen to associates and associates bring something to the table. As a client, I like knowing there is direction from an experienced partner but that work is delegated to an invested associate when appropriate. The advice received is very practical.’
‘I have found the individuals approachable and nimble. They adapt their style, which has ranged from aggressive when required to conciliatory. I have appreciated that they never lose sight of our key objectives, their advice is commercial and practical.’
‘A small, but excellent team, focused on delivering for their clients. Real expertise in fund and company litigation.’
‘I have been particularly impressed with the quality of their senior associates. Grace Boos, in particular, shows great maturity and insight. One to watch for the future.’
Corporate and commercial > EU and competition
Corporate and commercial > Financial services: non-contentious/regulatory
Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
Employment > Employers
Investment fund formation and management > Fund finance
TMT (technology, media and telecoms) > IT and telecoms
Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
Dispute resolution > Banking litigation: investment and retail
East Anglia > Corporate and commercial > Corporate and commercial: Cambridge
Goodwin's Cambridge office is a key hub for the firm-wide technology and life sciences practice, which has a prominent global profile. The firm advises private and public companies, venture capital funds and investment firms on early-stage financings, capital market transactions, M&A deals, strategic collaborations and licensing matters in this context. David Mardle, Malcolm Bates and Tim Worden are the lead partners. Adam Thatcher who was promoted to partner in October 2022 and Elizabeth Rhodes play key roles in tech in VC and M&A transaction work, namely. The team is noted as being ‘smart and responsive, with good depth of skill and experience in complex transactions'.Practice head(s):
Malcolm Bates; David Mardle; Tim Worden
Other key lawyers:
Adam Thatcher; Elizabeth Rhodes; Roshni Thakkar
Testimonials
‘Knowledgeable on venture capital, extremely responsive, good risk mitigations.’
‘We have a genuine relationship with the team who always seek to understand circumstances and context.’
‘Smart and responsive, with good depth of skill and experience in complex transactions.’
‘A trusted advisor with breadth of experience, responsiveness and availability.’
‘Extensive experience of commercial transactions; a highly pragmatic approach, efficient and expeditious in providing advice. Excellent value for money.’
‘Elizabeth Rhodes is extremely commercial and effective, and has a very talented group of associates including Roshni Thakkar, who deserves particular mention. The team is highly commercial with a focus on getting a deal done. They have proven excellent at learning how we as a client like to work with external advisers, and what our limits are, and now implement this consistently.’
‘We trust the Cambridge team’s judgement and have confidence in them striking the right balance between attention-to-detail and not overworking a matter. The team is well run, consistent in their approach, transitions are smooth and all are a pleasure to work with.’
‘Elizabeth Rhodes is highly commercial, a clear and efficient communicator, and resilient in negotiations. She learns her clients, their preferences and limits, and ensures that she and her team take as much as they can upon themselves. Roshni Thakkar is excellent – technically completely sound, has a strong commercial outlook, with excellent communication and project management skills.’
Key clients
Okra.ai
Refeyn Limited
Oxford Science Enterprises PLC
Syncona Portfolio Limited
Engitix Limited
SynAffix B.V.
Stalicla SA
Probe Test Solutions Limited
Ten Eleven Ventures
MiroBio Ltd
Flusso
Cleo
SV Health Investors
Jeito
Samsara BioCapital
Biocon Biologics Ltd
YASA
Moderna
Tay Therapeutics
Work highlights
- Advised OKRA.ai on their acquisition by Envision Pharma Group (Envision)
- Advised Refeyn on its oversubscribed Series B financing. The round was led by Northpond Ventures, a scientific, medical, and technology-driven venture firm and supported by existing investors, including Oxford Science Enterprises, Foresight Group, Oxford University and Horizons Ventures.
- Advised Oxford Science Enterprises PLC and Syncona Portfolio Limited on their investments into OMass Therapeutics Limited as part of OMass’s $100m Series B funding round alongside new investors GV, Northpond and Sanofi.
East Anglia > TMT (technology, media and telecoms) > Intellectual property
The Cambridge based team at Goodwin specialises in assisting clients with IPOs, financings, and patent strategies. The team recently assisted Engitix Therapeutics on a licence and collaboration agreement with Takeda Pharmaceuticals USA, Inc. Practice co-head Malcolm Bates specialises in the commercialisation of intellectual property rights, and co-head Tim Worden regularly advises life sciences companies on licensing and partnering deals, R&D and clinical trials agreements, and a broad spectrum of regulatory matters. Counsel Talitha Shkopiak focuses on commercial agreements, and associate Georgia Powell whose work encompasses early stage contractual disputes, are also pivotal to the practice.Practice head(s):
Malcolm Bates; Tim Worden
Other key lawyers:
Key clients
Engitix Limited
SynAffix B.V.
Stalicla SA
CMR Surgical
Gadeta
Pheon Therapeutics
MiNA Therapeutics
Avacta
SpyBiotech
Tenpoint Therapeutics
Work highlights
- Advised Synaffix B.V. on a license agreement with Amgen Inc.
- Advised Engitix Limited on entering into an expanded licence and collaboration agreement with Takeda Pharmaceuticals.
- Advised Stalicla SA on its exclusive in-licensing agreement with Novartis.
East Anglia > TMT (technology, media and telecoms) > Biotechnology
At Goodwin in Cambridge, ‘the team provides timely, pragmatic and and commercial advice‘ and clients note that the lawyers are ‘accessible, responsive and keen to understand our aims‘. David Mardle has broad expertise in life sciences, technology, M&A, and finance matters; commercial IP specialist Malcolm Bates, who has ‘broad and long experience' in R&D projects and collaboration agreements; and licensing and contracts expert Tim Worden are key to the practice. Worden acted as part of a multinational team to advise Biocon Biologics on its multibillion-dollar acquisition of the global biosimilars business of its partner Viatris Inc. Up-and-coming partner Elizabeth Rhodes handles corporate and venture capital matters for technology and life sciences companies.Practice head(s):
Malcolm Bates; David Mardle; Tim Worden
Other key lawyers:
Testimonials
‘The team provides timely, pragmatic and and commercial advice on our licensing activities which we find very valuable. They are accessible, responsive and keen to understand our aims during transactions and regularly help us navigate complex scenarios given their knowledge and expertise in the market.’
‘Tim Worden provides us with expert coverage as our key contact as well as high quality, deal-specific advice on our licensing activities. He has pulled in trans-Atlantic resources on deals when we have needed it seamlessly and delivers a really high-quality service.’
‘We work especially with Malcolm Bates. Malcolm’s broad and long experience makes interactions and processes run smoothly and efficiently.’
Key clients
Biocon Biologics
Syndesi Therapeutics
Okrai.ai
Refeyn Limited
Oxford Science Enterprises PLC
Engitix Therapeutics
Synaffix BV
Stalicla SA
Ten Eleven Ventures III, LP
MiroBio Ltd
SV Health Investors
CMR Surgical
Ochre Bio, Inc
Gadeta
Work highlights
- Advised Biocon Biologics Ltd on its multi-billion-dollar acquisition of the global biosimilars business of its partner Viatris Inc.
- Advised Synaffix B.V on three license agreements: with Genmab A/S; with Amgen Inc; with Hummingbird Bioscience.
- Advised Stalicla SA on an in-licensing agreement with Novartis.
Goodwin > Firm Profile
With the breakneck pace of technology disrupting industries around the world, our London-based team of 220+ lawyers is embracing change to help clients make a lasting and meaningful impact. As part of what is widely recognised as one of the fastest growing international firms in London, our lawyers are deeply experienced in the life sciences, technology, real estate and private equity sectors and are supported by significant on-the-ground capabilities in debt financing, intellectual property, privacy and cybersecurity, regulatory, restructuring, tax and litigation and dispute resolution.
In 2019 we also launched our Cambridge office in the heart of the high-technology Silicon Fen, and home to one of the world’s largest and most innovative life sciences clusters, as well as some of the most disruptive technology and life sciences companies. The firm’s on-the-ground presence in Cambridge further expands our lawyers’ ability to support clients in these sectors through our unique capital-meets-innovation platform in Europe, and solidifies Goodwin’s position as the leading firm in the UK and European life sciences and technology markets.
Real estate: Our real estate lawyers provide a genuinely integrated offering from structuring funds, products and vehicles, to the acquisition, financing, development, restructuring and disposal of real estate assets through direct and indirect investments, as well as complex international hospitality + leisure transactions.
Private equity: Our private equity lawyers counsel on all areas of private equity and mergers and acquisitions, with a special emphasis on middle market private equity and growth investments, alongside our renowned private funds team, which provides counsel at every stage of the fund life cycle.
Technology and life sciences: Our technology and life sciences lawyers help high growth businesses, public companies, investors and investment banks capitalise on opportunities and minimise risks in rapidly evolving markets. We offer clients industry-leading technology, life sciences and healthcare practices recognized for serving clients along the corporate life cycle globally.
Private investment funds: Goodwin’s London funds team uniquely covers the full range of private investment funds including private equity funds, venture capital funds, real estate funds, infrastructure funds, debt funds, impact and responsible investing funds, emerging market funds, hedge funds and listed funds as well as various large-scale GP led structures.
Tax: Our tax team have extensive experience of the tax issues affecting the private equity, infrastructure and real estate industries. This sector focus means that our tax team can save you time and money by delivering pragmatic and commercially relevant advice grounded not only in technical expertise and experience but also in a deep understanding of the issues affecting the markets in which you operate. By working as integral parts of our transaction and fund formation teams to ensure that tax advice is robustly implemented, our tax lawyers minimise the risk of challenge by a tax authority and the cost and possible reputational damage that can result from such a challenge.
Restructuring: Our London financial restructuring lawyers represent every type of major stakeholder in distressed situations. The restructuring and insolvency advice provided by our team complements the other services provided by Goodwin during the full life cycle of each company and investment to achieve the optimum outcome for stakeholders
Litigation: Our London team has over 20 years’ experience advising investment and retail banks, funds, issuers, bondholders and other financial counter-parties in the resolution of complex corporate disputes, often with a cross-border element. The team has litigated across many different fields of finance, with a particular focus on investment banking, structured finance and funds litigation.
Regulatory: Our regulatory team is uniquely positioned to address the cutting-edge issues that can maximize business opportunities as well as better manage and mitigate risk. Our team of specialists represent investment managers on the formation, offering and operation of investment products including real estate, private equity, infrastructure + energy, private debt, hedge, venture funds, fund of funds, and joint ventures. We have experience advising clients on matters under the EU AIFMD, EU MIFID, UK Financial Services and Markets Act 2000 and the UK Financial Conduct Authority’s Rules and are currently helping clients navigate their way through the post-Brexit landscape. We also advise clients on issues relating to the US Investment Advisers Act of 1940 and the US Investment Company Act of 1940 including registration and compliance matters.
Privacy and cybersecurity: Goodwin’s team focuses on technology transactions and the commercialisation of technology, data and intellectual property rights, and counsels on related EU regulatory compliance, including EU data protection (GDPR), privacy and cybersecurity and EU competition “safe harbour” regimes and EU agency laws.
Employment: Goodwin’s employment team advises clients on issues in all areas of contentious and non-contentious employment law, including on the employment law aspects of corporate disposals and acquisitions.
Main Contacts
Department | Name | Telephone | |
---|---|---|---|
London Office Co-Chair | Ajay Pathak | APathak@goodwinlaw.com | +44 (0)20 7447 4855 |
London Office Co-Chair | Gemma Roberts | GRoberts@goodwinlaw.com | +44 (0)20 7447 4204 |
Lawyer Profiles
Photo | Name | Position | Profile |
---|---|---|---|
Mark Beardsworth | Partner | View Profile | |
Bill Schnoor | Partner | View Profile |
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Corporate and commercial > Venture capital
- Investment fund formation and management > Real estate funds
- Corporate and commercial > Corporate and commercial: Cambridge
- TMT (technology, media and telecoms) > Biotechnology
- TMT (technology, media and telecoms) > Intellectual property
Top Tier Firm Rankings
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Investment fund formation and management > Private funds
Firm Rankings
- Industry focus > Hospitality and leisure
- Industry focus > Life sciences and healthcare
- Real estate > Commercial property: investment
- Corporate and commercial > Corporate tax
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Real estate > Property finance
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > Fintech
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Employment > Employers
- Investment fund formation and management > Fund finance
- TMT (technology, media and telecoms) > IT and telecoms